Business Overview: The Joint Corp. (NASDAQ: JYNT)

---

Executive Summary

The Joint Corp. is a franchisor (and, in a shrinking minority of locations, direct operator) of chiropractic clinics operating under the brand "The Joint Chiropractic." The company was built around a cash-pay, insurance-free, appointment-free model that makes routine chiropractic adjustments cheap and convenient — walk-in visits, open adjustment bays, and flat, low prices (roughly $36 average per visit versus an estimated ~$76 industry average for cash-pay chiropractic care). As of the end of fiscal 2024 the system had 967 clinics across 41 states and D.C., with the large majority already franchised and the company in the final stages of divesting its remaining company-owned clinics.

The company is executing a multi-year strategic pivot from a hybrid franchisor/operator to a "pure-play" asset-light franchisor, selling off its last company-owned-or-managed clinics to existing and new franchisees. By mid-2025 franchised units represented about 92% of the system.

Why it matters: JYNT is one of the few at-scale, branded consolidators in the highly fragmented U.S. chiropractic industry (roughly 38,000+ independent practices, with the top 50 practices holding only ~4% of industry revenue), and its shift to a royalty-based franchise model should raise margins and reduce capital intensity going forward.

---

1. Core Business Model & How They Work

The Joint Corp. makes money primarily by licensing its brand, systems, and marketing to independent franchisees who open and run "The Joint Chiropractic" clinics, rather than by treating patients itself.

Revenue streams:

• Royalties — 7.0% of gross sales from each franchised clinic.
• National marketing fund fees — 2.0% of gross sales from each franchised clinic.
• Initial franchise fees — $39,900 per license (discounted for multi-unit buyers).
• Regional developer economics — regional developers earn up to 50% of franchise fees they generate plus 3% of royalties, in exchange for field support.
• Legacy company-owned clinic revenue — being wound down, now reported as discontinued operations.

                 PATIENT VISITS (cash/card, no insurance)
                             |
                             v
          ┌──────────────────────────────────────┐
          │   FRANCHISED "THE JOINT" CLINIC        │
          │  (owned/operated by franchisee)        │
          └──────────────────────────────────────┘
                 |  7% royalty + 2% ad fund fee
                 |  (ongoing, % of gross sales)
                 v
          ┌──────────────────────────────────────┐
          │       THE JOINT CORP. (franchisor)     │
          │  brand, systems, national marketing,   │
          │  training, regional developer network  │
          └──────────────────────────────────────┘
                 ^
                 |  $39,900 initial franchise fee
                 |  (one-time, per new clinic sold)
          ┌──────────────────────────────────────┐
          │     NEW FRANCHISEE / MULTI-UNIT OWNER   │ ➡️ opens new clinic
          └──────────────────────────────────────┘

---

2. Product Portfolio

---

3. Competitive Landscape

• Insurance-based multi-unit chiropractic chains (Airrosti, HealthSource Chiropractic, 100% Chiropractic, ChiroOne) — operate on an insurance-reimbursement model with associated billing complexity; The Joint's non-insurance model is explicitly differentiated.
• Direct cash-pay copycats — about six franchised competitors attempt the same model; the largest has only ~34 franchised clinics versus The Joint's ~967, roughly a 6x scale advantage.
• Independent solo chiropractic practices — the vast majority of ~38,000+ U.S. chiropractic offices, fragmented and unbranded.

                 Cash-pay / no insurance
                          ^
                          |
      Direct copycats     |      THE JOINT CORP.
   (small franchised      |   (967 clinics, brand,
    chains, <35 units)    |    national marketing)
                          |
  <----------------------+----------------------->
  Low scale / local           High scale / national
                          |
   Independent solo       |   Insurance-based chains
   practices (~38,000)    |   (Airrosti, ChiroOne,
                          |    HealthSource, 100% Chiro)
                          |
                 Insurance-reimbursed

---

4. Strategic Strengths & Risks

Strengths (moat sources):

• Brand scale in a fragmented category — roughly 6x the size of its nearest direct (cash-pay franchise) competitor.
• Franchise flywheel — a largely fixed-cost corporate structure collecting a percentage of system-wide sales improves operating leverage as the franchised base grows.
• Low-price positioning — pricing roughly half the broader cash-pay chiropractic average is a durable value proposition, though replicable over time.

Risks:

• Franchisee unit economics / royalty base concentration — royalty revenue depends on the health of several hundred independent franchisees.
• Refranchising execution risk — still mid-transition out of company-owned clinics.
• Competitive replication — the model is not patent-protected.
• Regulatory/licensing exposure — chiropractic practice is state-regulated.
• Macro sensitivity — discretionary, out-of-pocket wellness spending could be pressured in a weaker consumer environment.

---

5. Financial Overview

---

6. Summary Conclusion

The Joint Corp.'s moat rests on brand scale within a fragmented, underpenetrated category — it is the clear leader among cash-pay chiropractic franchise chains, with a multiple-times scale advantage over its nearest direct copycat. As the company completes its multi-year refranchising transition to a pure royalty-based franchisor, the business should become structurally higher-margin and less capital-intensive, which the recent gross-margin trend and swing to net income already partially reflect.

The biggest forward risk is execution and durability of franchisee-level unit economics: because nearly all of JYNT's revenue now flows from a percentage of franchisee sales, any slowdown in same-store sales growth, franchisee profitability, or new-unit development pace would compress royalty and marketing-fund revenue directly, with limited near-term offsetting levers once the refranchising transition itself is finished.